Monica Benincasa

Monica Benincasa

Auto-generated profile, based on publicly available information

Monica Benincasa

Department of Life Sciences, University of Trieste, 34127 Trieste, Italy

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2005 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
WWWei Wu
Wei Wu
SWSébastien Wieckowski
Sébastien Wieckowski
GPGiorgia Pastorin
Giorgia Pastorin
MBMonica Benincasa
Monica Benincasa
CKCédric Klumpp
Cédric Klumpp
Alberto BiancoAlberto Bianco
Alberto Bianco

30 April 2009 in Biomacromolecules
Verified
Journal Article
Closed access
ATAndrea Travan
Andrea Travan
CPChiara Pelillo
Chiara Pelillo
Ivan DonatiIvan Donati
Ivan Donati
Eleonora MarsichEleonora Marsich
Eleonora Marsich
MBMonica Benincasa
Monica Benincasa
SPSergio Paoletti
Sergio Paoletti

1 March 2016 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
DXDaniela Xhindoli
Daniela Xhindoli
SPSabrina Pacor
Sabrina Pacor
MBMonica Benincasa
Monica Benincasa
MSMarco Scocchi
Marco Scocchi
RGRenato Gennaro
Renato Gennaro
SPSabrina Pacor
Sabrina Pacor

28 August 2007 in Molecular Microbiology
Verified
Journal Article
Closed access
PDF file
MMMaura Mattiuzzo
Maura Mattiuzzo
ABAntonella Bandiera
Antonella Bandiera
RGRenato Gennaro
Renato Gennaro
MBMonica Benincasa
Monica Benincasa
sabrina pacorsabrina pacor
sabrina pacor
MSMarco Scocchi
Marco Scocchi

16 September 2015 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
MSMarco Scocchi
Marco Scocchi
MMMario Mardirossian
Mario Mardirossian
GRGiulia Runti
Giulia Runti
MBMonica Benincasa
Monica Benincasa
Antimicrobial peptides (AMPs) are a large class of innate immunity effectors with a remarkable capacity to inactivate microorganisms. Their ability to kill bacteria by membranolytic effects has been well established. However, a lot of evidence points to alternative, non-lytic modes of action for a number of AMPs, which operate through interactions with specific molecular targets. It has been reported that non-membrane-permeabilizing AMPs can bind to and inhibit DNA, RNA or protein synthesis processes, inactivate essential intracellular enzymes, or affect membrane septum formation and cell wall synthesis. This minireview summarizes recent findings on these alternative, non-lytic modes of antimicrobial action with an emphasis to the experimental approaches used to clarify each step of their intracellular action, i.e. the cell penetration mechanism, intracellular localization and molecular mechanisms of antibacterial action. Despite the fact that such data exists for a large number of peptides, our analysis indicates that only for a small number of AMPs sufficient data have been collected to support a mode of action with an authentic and substantial contribution by intracellular targeting. In most cases, peptides with non-lytic features have not been thoroughly analyzed, or only a single aspect of their mode of action has been taken into consideration and therefore their mechanism of action can only be hypothesized. A more detailed knowledge of this class of AMPs would be important in the design of novel antibacterial agents against unexploited targets, endowed with the capacity to penetrate into pathogen cells and kill them from within.

7 December 1999 in FEBS Letters
Verified
Journal Article
Closed access
BSBarbara Skerlavaj
Barbara Skerlavaj
MBMonica Benincasa
Monica Benincasa
ARAngela Risso
Angela Risso
MZMargherita Zanetti
Margherita Zanetti
RGRenato Gennaro
Renato Gennaro